<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nid</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология и диализ</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology and Dialysis</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1680-4422</issn><issn pub-type="epub">2618-9801</issn><publisher><publisher-name>Российское диализное общество</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">nid-823</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПРАКТИЧЕСКИЕ РЕКОМЕНДАЦИИ</subject></subj-group></article-categories><title-group><article-title>Комментарии European Renal Best Practice к Рекомендациям KDIGO по Минеральным и Костным Нарушениям при Хронической Болезни Почек (Краткое изложение)</article-title><trans-title-group xml:lang="en"><trans-title>European Renal Best Practice: Comments to KDIGOCKD-MBD</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Голдсмит</surname><given-names>Д. .</given-names></name><name name-style="western" xml:lang="en"><surname>Goldsmith</surname><given-names>D. J.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кович</surname><given-names>А. .</given-names></name><name name-style="western" xml:lang="en"><surname>Covic</surname><given-names>A. .</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фуке</surname><given-names>Д. .</given-names></name><name name-style="western" xml:lang="en"><surname>Fouque</surname><given-names>D. .</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Локателли</surname><given-names>Ф. .</given-names></name><name name-style="western" xml:lang="en"><surname>Locatelli</surname><given-names>F. .</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Олгард</surname><given-names>К. .</given-names></name><name name-style="western" xml:lang="en"><surname>Olgaard</surname><given-names>K. .</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Родригес</surname><given-names>М. .</given-names></name><name name-style="western" xml:lang="en"><surname>Rodriguez</surname><given-names>M. .</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Спасовский</surname><given-names>Г. .</given-names></name><name name-style="western" xml:lang="en"><surname>Spasovski</surname><given-names>G. .</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Урена</surname><given-names>П. .</given-names></name><name name-style="western" xml:lang="en"><surname>Urena</surname><given-names>P. .</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зокалли</surname><given-names>К. .</given-names></name><name name-style="western" xml:lang="en"><surname>Zoccali</surname><given-names>C. .</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лондон</surname><given-names>Ж. -М.</given-names></name><name name-style="western" xml:lang="en"><surname>London</surname><given-names>G. -M.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ванхолдер</surname><given-names>Р. .</given-names></name><name name-style="western" xml:lang="en"><surname>Vanholder</surname><given-names>Raymond</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email></contrib></contrib-group><pub-date pub-type="collection"><year>2011</year></pub-date><pub-date pub-type="epub"><day>17</day><month>06</month><year>2025</year></pub-date><volume>13</volume><issue>1</issue><fpage>14</fpage><lpage>19</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Голдсмит Д..., Кович А..., Фуке Д..., Локателли Ф..., Олгард К..., Родригес М..., Спасовский Г..., Урена П..., Зокалли К..., Лондон Ж.-., Ванхолдер Р..., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Голдсмит Д..., Кович А..., Фуке Д..., Локателли Ф..., Олгард К..., Родригес М..., Спасовский Г..., Урена П..., Зокалли К..., Лондон Ж.-., Ванхолдер Р...</copyright-holder><copyright-holder xml:lang="en">Goldsmith D.J., Covic A..., Fouque D..., Locatelli F..., Olgaard K..., Rodriguez M..., Spasovski G..., Urena P..., Zoccali C..., London G.-., Vanholder R.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephro.ru/jour/article/view/823">https://journal.nephro.ru/jour/article/view/823</self-uri><abstract><p>В 2008 году группа экспертов Европейской Ассоциации заболеваний Почек, Диализа и Трансплантации (ERA-EDTA) подготовила документ, на основании которого было принято решение о том, что под названием «guidelines» (дословно – «руководство», «стандарты», «принципы», «методические рекомендации») Ассоциация будет выпускать лишь положения, обоснованные доказательствами высокого уровня (в соответствии с системой GRADE). Положения, подтверждаемые свидетельствами низкого уровня или представляющие собой мнения экспертов, будут обозначаться как «recommendations». Основанием для такого решения послужило то обстоятельство, что опубликованные методические рекомендации, даже в тех случаях, когда отмечено, что они основываются на свидетельствах низкого уровня доказательности, воспринимаются нефрологическим сообществом как истина в последней инстанции. Это решение нашло отражение в изменении названия широко известной инициативы European Best Practice Guidelines (EBPG) на European Renal Best Practice (ERBP) [<xref ref-type="bibr" rid="cit15">15</xref>]. Комментарии ERBP к Рекомендациям KDIGO по Минеральным и Костным Нарушениям при Хронической Болезни Почек (МКН-ХБП) опубликованы в журнале «Nephrology Dialysis Transplantation» в электронном виде (в открытом доступе) 9 сентября 2010 г. (doi: 10.1093/ndt/gfq513) [<xref ref-type="bibr" rid="cit9">9</xref>] и ниже представлено их сокращенное изложение. Перевод А.Ю. Земченкова, Р.П. Герасимчука</p></abstract></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Adragao T., Herberth J., Monier-Faugere M.C. et al. Femoral bone mineral density reflects histologically determined cortical bone volume in hemodialysis patients // Osteoporos Int. 2010. Vol. 21. P. 619–625.</mixed-citation><mixed-citation xml:lang="en">Adragao T., Herberth J., Monier-Faugere M.C. et al. Femoral bone mineral density reflects histologically determined cortical bone volume in hemodialysis patients // Osteoporos Int. 2010. Vol. 21. P. 619–625.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Amerling R., Harbord N.B., Pullman J. et al. Bisphosphonate use in chronic kidney disease: association with adynamic bone disease in a bone histology series // Blood Purif. 2010. Vol. 29. P. 293–299.</mixed-citation><mixed-citation xml:lang="en">Amerling R., Harbord N.B., Pullman J. et al. Bisphosphonate use in chronic kidney disease: association with adynamic bone disease in a bone histology series // Blood Purif. 2010. Vol. 29. P. 293–299.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Barretto F.C., Barreto D.V., Moyses R.M. et al. K/DOQI-recommended intact PTH levels do not prevent low turnover bone disease in hemodialysis patients // Kidney Int. 2008. Vol. 73. P. 771–777.</mixed-citation><mixed-citation xml:lang="en">Barretto F.C., Barreto D.V., Moyses R.M. et al. K/DOQI-recommended intact PTH levels do not prevent low turnover bone disease in hemodialysis patients // Kidney Int. 2008. Vol. 73. P. 771–777.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Block G.A., Persky M.S., Ketteler M. et al. A randomized double-blind pilot study of serum phosphorus normalization in chronic kidney disease: a new paradigm for clinical outcomes studies in nephrology // Hemodial. Int. 2009. Vol. 13. P. 360–362.</mixed-citation><mixed-citation xml:lang="en">Block G.A., Persky M.S., Ketteler M. et al. A randomized double-blind pilot study of serum phosphorus normalization in chronic kidney disease: a new paradigm for clinical outcomes studies in nephrology // Hemodial. Int. 2009. Vol. 13. P. 360–362.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Covic A., Kothawala P., Bernal M. et al. Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease // Nephrol Dial Transplant. 2009. Vol. 24. P. 1506–1523.</mixed-citation><mixed-citation xml:lang="en">Covic A., Kothawala P., Bernal M. et al. Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease // Nephrol Dial Transplant. 2009. Vol. 24. P. 1506–1523.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Drüeke T.B., Ritz E. Treatment of secondary hyperparathyroidism in CKD patients with cinacalcet and/or vitamin D derivatives // Clin J Am Soc Nephrol. 2009. Vol. 4. P. 234–241.</mixed-citation><mixed-citation xml:lang="en">Drüeke T.B., Ritz E. Treatment of secondary hyperparathyroidism in CKD patients with cinacalcet and/or vitamin D derivatives // Clin J Am Soc Nephrol. 2009. Vol. 4. P. 234–241.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Fouque D., Vennegoor M., ter Wee P. et al. EBPG guideline on nutrition // Nephrol Dial Transplant. 2007. Vol. 22. P. ii45–ii87.</mixed-citation><mixed-citation xml:lang="en">Fouque D., Vennegoor M., ter Wee P. et al. EBPG guideline on nutrition // Nephrol Dial Transplant. 2007. Vol. 22. P. ii45–ii87.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Goldsmith D. Routine screening for vascular calcification in chronic kidney disease – the case against // Semin Dial. 2010. Vol. 23. P. 280–282.</mixed-citation><mixed-citation xml:lang="en">Goldsmith D. Routine screening for vascular calcification in chronic kidney disease – the case against // Semin Dial. 2010. Vol. 23. P. 280–282.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Goldsmith D.J., Covic A., Fouque D. et al. Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement // Nephrol Dial Transplant. 2010 Sep 9. [Epub ahead of print] doi: 10.1093/ndt/gfq513.</mixed-citation><mixed-citation xml:lang="en">Goldsmith D.J., Covic A., Fouque D. et al. Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement // Nephrol Dial Transplant. 2010 Sep 9. [Epub ahead of print] doi: 10.1093/ndt/gfq513.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Kuhlmann M.K. Phosphate elimination in modalities of hemodialysis and peritoneal dialysis // Blood Purif. 2010. Vol. 29. P. 137–144.</mixed-citation><mixed-citation xml:lang="en">Kuhlmann M.K. Phosphate elimination in modalities of hemodialysis and peritoneal dialysis // Blood Purif. 2010. Vol. 29. P. 137–144.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">London G.M. Awareness of vascular calcification alters mineral metabolism management // Semin Dial. 2010. Vol. 23. P. 267–270.</mixed-citation><mixed-citation xml:lang="en">London G.M. Awareness of vascular calcification alters mineral metabolism management // Semin Dial. 2010. Vol. 23. P. 267–270.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Moore C., Yee J., Malluche H. et al. Relationship between bone histology and markers of bone and mineral metabolism in African-American hemodialysis patients // Clin J Am Soc Nephrol. 2009. Vol. 4. P. 1484–1493.</mixed-citation><mixed-citation xml:lang="en">Moore C., Yee J., Malluche H. et al. Relationship between bone histology and markers of bone and mineral metabolism in African-American hemodialysis patients // Clin J Am Soc Nephrol. 2009. Vol. 4. P. 1484–1493.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Souberbielle J.C., Cavalier E., Jean G. Interpretation of serum parathyroid hormone concentrations in dialysis patients: what do the KDIGO guidelines change for the clinical laboratory // Clin Chem Lab Med. 2010. Vol. 48. P. 769–774.</mixed-citation><mixed-citation xml:lang="en">Souberbielle J.C., Cavalier E., Jean G. Interpretation of serum parathyroid hormone concentrations in dialysis patients: what do the KDIGO guidelines change for the clinical laboratory // Clin Chem Lab Med. 2010. Vol. 48. P. 769–774.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Tonelli M., Wang W., Hemmelgarn B. et al. Alberta Kidney Disease Network. Phosphate removal with several thrice-weekly dialysis methods in overweight hemodialysis patients // Am J Kidney Dis. 2009. Vol. 54. P. 1108–1115.</mixed-citation><mixed-citation xml:lang="en">Tonelli M., Wang W., Hemmelgarn B. et al. Alberta Kidney Disease Network. Phosphate removal with several thrice-weekly dialysis methods in overweight hemodialysis patients // Am J Kidney Dis. 2009. Vol. 54. P. 1108–1115.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Zoccali C., Abramowicz D., Cannata-Andia J.B. et al. European best practice quo vadis? From European Best Practice Guidelines (EBPG) to European Renal Best Practice (ERBP) // Nephrol Dial Transplant. 2008. Vol. 23. № 7. P. 2162–2166.</mixed-citation><mixed-citation xml:lang="en">Zoccali C., Abramowicz D., Cannata-Andia J.B. et al. European best practice quo vadis? From European Best Practice Guidelines (EBPG) to European Renal Best Practice (ERBP) // Nephrol Dial Transplant. 2008. Vol. 23. № 7. P. 2162–2166.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
